Across TCGA pan-cancer cohorts, VPS33A RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated VPS33A data layer compared with 7 for mutation status and 5 for mass-spec protein.
The strongest signal is observed in kidney chromophobe (KICH), where higher VPS33A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VPS33A expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRC show a favorable association.
KICH, LIHC, and UCS are the cancer types where VPS33A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.